πŸ‡ΊπŸ‡Έ FDA
Patent

US 6858712

Cloning and expression of HTLV-III DNA

expired A61KA61K38/00

Quick answer

US patent 6858712 (Cloning and expression of HTLV-III DNA) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00